Screening for fetal aneuploidies at 11 to 13 weeks
Top Cited Papers
- 5 January 2011
- journal article
- review article
- Published by Wiley in Prenatal Diagnosis
- Vol. 31 (1) , 7-15
- https://doi.org/10.1002/pd.2637
Abstract
Effective screening for major aneuploidies can be provided in the first trimester of pregnancy. Screening by a combination of fetal nuchal translucency and maternal serum free‐β‐human chorionic gonadotrophin and pregnancy‐associated plasma protein‐A can identify about 90% of fetuses with trisomy 21 and other major aneuploidies for a false‐positive rate of 5%. Improvement in the performance of first‐trimester screening can be achieved by firstly, inclusion in the ultrasound examination assessment of the nasal bone and flow in the ductus venosus, hepatic artery and across the tricuspid valve, and secondly, carrying out the biochemical test at 9 to 10 weeks and the ultrasound scan at 12 weeks. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
Funding Information
- Fetal Medicine Foundation
This publication has 106 references indexed in Scilit:
- Two‐stage first‐trimester screening for trisomy 21 by ultrasound assessment and biochemical testingUltrasound in Obstetrics & Gynecology, 2010
- Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestationUltrasound in Obstetrics & Gynecology, 2009
- Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free -hCG and pregnancy-associated plasma protein-AHuman Reproduction, 2008
- Genetic sonography after first‐trimester Down syndrome screeningUltrasound in Obstetrics & Gynecology, 2007
- Nasal bone in first-trimester screening for trisomy 21American Journal of Obstetrics and Gynecology, 2006
- The first trimester ‘combined test’ for the detection of Down syndrome pregnancies in 4939 unselected pregnanciesPrenatal Diagnosis, 2002
- Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational studyThe Lancet, 2001
- Increased nuchal translucency thickness at l0–14 weeks of gestation as a predictor of severe twin‐to‐twin transfusion syndromeUltrasound in Obstetrics & Gynecology, 1997
- Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestationBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1988